Formulation development can involve several complex technical challenges, but an approach incorporating design of experiments can help address these difficulties. All pharmaceutical drug products are ...

Study Designed to Establish the Optimal Dose of GENEVAX™ IL-12 Adjuvant in Formulation with the Profectus Multi-Antigen Therapeutic HIV DNA Vaccine when Delivered with the Ichor Medical Systems’ ...

At BIOVECTRA (2022-present), Jessica supports business development efforts for pDNA, mRNA, and formulation services. About the Drug Solutions Podcast Pharmaceutical Technology presents the Drug ...

The emerging field of mRNA therapeutics is still young. This class of therapeutics is poised to have broad implications in the treatment of many indications in addition to infectious diseases such as ...

Expansion will help meet the growing demand for plasmid DNA offerings SEATTLE, June 30, 2020 /PRNewswire/ -- Committed to continuous innovation and expansion of its service offerings, AGC Biologics ...

Cationic liposome represents a promising alternative to viral vectors for the delivery of therapeutic genes. For in vivo use, surface modification of the liposome with polyethylene glycol (PEG) is ...

Circular double-stranded plasmid DNA (pDNA) plays a crucial role in vaccine development, cell and gene therapy, and recombinant protein or mAb production. These small pieces of DNA carry targeted ...

HOUSTON--(BUSINESS WIRE)-- Bionova Scientific ®, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced ...

Genetic Immunity has successfullty developed a stable, liquid formulation of a topically-administered nanomedicine vaccine for the treatment of HIV/AIDS. With results reported in the International ...